INSIGHTS ON CLINICAL TRIAL DESIGN
-
![Home Diabetes Treatment iStock-1127801655]( "Bringing Clinical Trials To Everyone's Backyard")
Bringing Clinical Trials To Everyone's BackyardLearn how bringing clinical trials to any community around the world is not only possible but also increases patient access and reach and improves recruitment and retention.
-
![Winning strategy efficiency innovation-+GettyImages-1359225856]( "What Everest Group's RTSM Recognition Means For The Industry")
What Everest Group's RTSM Recognition Means For The IndustryRTSM is transforming from a basic operational tool into a strategic driver of trial efficiency. Learn why industry recognition signals a new era of innovation and competitive advantage.
-
![Digital Eye-GettyImages-2184122570]( "When Your Protocol Includes Ocular Endpoints")
When Your Protocol Includes Ocular EndpointsStandardizing ocular endpoint execution reduces participant dropout and eliminates data variability. Specialized oversight secures clinical timelines and ensures high-quality, submission-ready data.
-
![Human Abuse Potential Participant Recruitment]( "Human Abuse Potential: Participant Recruitment")
Human Abuse Potential: Participant RecruitmentTake a look at the strategies behind successful human abuse potential studies, from volunteer recruitment models to retention challenges, and how participant experience directly impacts data quality.
-
Beyond The Database: Reaching Real Patients In Real Communities5/14/2025
There’s fatigue around “database-only” recruitment tactics. This presentation spotlights how patient-centric, local engagement are outperforming traditional pipelines.
-
Adaptive Clinical Trials: Innovation With Hidden Challenges5/8/2026
Adaptive trial designs offer faster results and better patient care, but only if site infrastructure can keep up with the operational complexity of these highly flexible research models.
-
A 2025 Survey Report Uncovers The Top 5 Clinical Trial Cost Insights4/22/2025
In this 2025 survey of over 100 U.S. clinical trial participants and caregivers, we reveal that most individuals join trials seeking life-saving treatment, not financial gain.
-
No More Swiss Holes: Filling The Gaps In Clinical Trial Disclosure1/14/2026
This use case shows how sponsors can gain clarity on disclosure requirements when entering a new country.
-
How Home Trial Visits Support Sites And Patients3/20/2025
By reaching into the heart of communities, Home Trial Support plays an invaluable role in driving the development of lifesaving, representative, medicines and therapies.
CLINICAL TRIAL DESIGN SOLUTIONS
-
![Doctor talking to patient-GettyImages-1330555438]( "Supporting Patients For Better Clinical Trials")
From our inception, Ergomed has been committed to enhancing the patient journey in clinical trials. Our unique Ergomed CARE™ approach revolutionizes trials by optimizing the patient experience. Designed to address and resolve issues proactively, this comprehensive approach supports and engages all stakeholders, leading to accelerated study start-up, improved patient recruitment and retention, and investigator engagement.
-
![Getty Images- 1404912459 oncology]( "Making The Impossible Possible In Oncology And Hematology Clinical Development")
When the complexities of designing and executing cancer trials in a highly competitive market can mean delays in delivering urgently needed treatments to patients, it pays to have a trusted partner by your side.
-
![GettyImages-1083316464_eye]( "Your Top Partner For Ophthalmic Drug Development")
As a leading partner in ocular therapy, Altasciences is at the forefront of ophthalmic drug development. Our integrated CRO/CDMO solutions can support your program from lead candidate selection to market. You will benefit from working with a single partner as your product advances through each phase of drug development—from prototype formulation through preclinical testing, to early phase clinical trials, and manufacturing. This could mean up to 40% in time savings.
-
![Kidneys]( "Turnkey Solutions For Your Renal And Hepatic Impairment Studies")
With three clinical pharmacology units, access to 145,000+ hepatic/renal patients, and 100+ completed studies, we’re your partner for NDA-enabling trials.
-
![GettyIMages-1216658919 neurology]( "Driving Successful In CNS And Neurology Trials")
Second, only to Oncology, CNS, and Neurology clinical trials are incredibly complex and complicated to navigate.
